Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
International Immunopharmacology|November 12, 2025
Macrophage polarization in tumors: The impact of efferocytosisYuLing Zhang, Hongjing Zang, Qiuyuan WenCancer Chemotherapy and Pharmacology|August 13, 2016
The role of microRNAs in resistance to targeted treatments of non-small cell lung cancerHongjing Zang, Weiyuan Wang, Songqing FanJournal of Experimental & Clinical Cancer Research : CR|June 16, 2023
AXL in cancer: a modulator of drug resistance and therapeutic targetYaoxiang Tang, Hongjing Zang, Qiuyuan Wen, et al.Frontiers in Oncology|May 16, 2020
Hyperprogression After Immune-Checkpoint Inhibitor Treatment: Characteristics and HypothesesHongjing Zang, Jinwu Peng, Hongmei Zheng, et al.Journal of Cancer|November 21, 2017
Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancerHongjing Zang, Jianlun Peng, Weiyuan Wang, et al.Journal of Cancer|July 9, 2019
Expression of WDR79 is associated with TP53 mutation and poor prognosis in surgically resected non-small cell lung cancerJinwu Peng, Yuting Zhan, Juan Feng, et al.International Journal of Cancer|March 8, 2026
Unraveling glymphatic disruption in brain tumors: Insights from perivascular space network analysisMin Gao, Hongjing Zang, Wei Zhao, et al.Scientific Reports|January 14, 2025
MicroRNA-150-3p enhances the antitumour effects of CGP57380 and is associated with a favourable prognosis in non-small cell lung cancerHongmei Zheng, Songqing Fan, Jiadi Luo, et al.Peerj|May 7, 2025
A comprehensive analysis identified an autophagy-related risk model for predicting recurrence and immunotherapy response in stage I lung adenocarcinomaHongmei Zheng, Songqing Fan, Hongjing Zang, et al.Plos One|January 27, 2025
Deep learning based analysis of G3BP1 protein expression to predict the prognosis of nasopharyngeal carcinomaLinshan Zhou, Mu Yang, Jiadi Luo, et al.Pageof 5